A Science and Technology Blog
In an email, Leena Menghaney, South Asia Head of Médecins Sans Frontières’s Access Campaign, says that the voluntary license will exclude India from even supplying raw materials (active pharmaceutical ingredients)…
Effects of vaccination The speed at which the virus had killed people slowed down a bit since summer this year — it took nearly four months to add one more million deaths…
Preliminary data, which is yet to be peer-reviewed, shows molnupiravir can reduce risk of hospitalisation or death by 50% in non-hospitalised adult patients with mild-to-moderate COVID-19 disease. The trial included…
“A single dose subcutaneous regimen of the antiviral Virafin will make the treatment more convenient for the patients. When administered early on during COVID, Virafin will help patients recover faster…
A ribonucleoside analog (β-D-N4-hydroxycytidine or NHC) that was previously shown to be effective against influenza and Ebola is also potent against coronaviruses, including the novel coronavirus. The prodrug of NHC…
Treating severe COVID-19 patients with the antiviral drug remdesivir does not quicken recovery, the first randomised, placebo-controlled, double-blind trial found. Although not statistically significant, those treated with the drug within…
One of the inhibitors that showed good antiviral activity against other coronaviruses was modified for enhanced antiviral activity. The inhibitor was found in the lungs even after 24 hours when…
Science Chronicle 